BRPI0924068A2 - vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma - Google Patents

vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma

Info

Publication number
BRPI0924068A2
BRPI0924068A2 BRPI0924068A BRPI0924068A BRPI0924068A2 BR PI0924068 A2 BRPI0924068 A2 BR PI0924068A2 BR PI0924068 A BRPI0924068 A BR PI0924068A BR PI0924068 A BRPI0924068 A BR PI0924068A BR PI0924068 A2 BRPI0924068 A2 BR PI0924068A2
Authority
BR
Brazil
Prior art keywords
coryza
preparation
vaccine against
recombinant vaccine
against infectious
Prior art date
Application number
BRPI0924068A
Other languages
English (en)
Inventor
Hiroshi Mizokami
Masashi Sakaguchi
Ryuichi Sakamoto
Susumu Baba
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Publication of BRPI0924068A2 publication Critical patent/BRPI0924068A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0924068A 2008-12-25 2009-12-24 vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma BRPI0924068A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008330448 2008-12-25
PCT/JP2009/071398 WO2010074126A1 (ja) 2008-12-25 2009-12-24 組換え鶏伝染性コリーザワクチン及びその製造方法

Publications (1)

Publication Number Publication Date
BRPI0924068A2 true BRPI0924068A2 (pt) 2016-07-26

Family

ID=42287733

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924068A BRPI0924068A2 (pt) 2008-12-25 2009-12-24 vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma

Country Status (9)

Country Link
US (2) US8647634B2 (pt)
EP (2) EP2382985B1 (pt)
JP (1) JP5568017B2 (pt)
KR (1) KR101652060B1 (pt)
CN (1) CN102333539B (pt)
BR (1) BRPI0924068A2 (pt)
ES (2) ES2537426T3 (pt)
MX (1) MX2011006903A (pt)
WO (1) WO2010074126A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267176B (zh) * 2015-05-12 2020-03-10 普莱柯生物工程股份有限公司 鸡传染性鼻炎疫苗组合物及其制备方法和应用
CN110540579B (zh) * 2018-05-29 2022-09-06 普莱柯生物工程股份有限公司 一种副鸡禽杆菌抗原蛋白、含有副鸡禽杆菌抗原的疫苗组合物、及其制备方法和应用
CN114573708B (zh) * 2020-11-30 2024-05-17 普莱柯生物工程股份有限公司 副鸡禽杆菌ha融合蛋白及其三聚体、制备的疫苗组合物、制备方法和应用
CN114262719B (zh) * 2021-12-07 2023-05-16 扬州优邦生物药品有限公司 副鸡嗜血杆菌三价基因工程亚单位疫苗制备方法及运用
CN117018174B (zh) * 2023-08-28 2024-05-28 武汉科前生物股份有限公司 用于副鸡禽杆菌a型的酿酒酵母口服疫苗及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58149956A (ja) 1982-03-02 1983-09-06 Sumitomo Chem Co Ltd セルロ−ス系繊維の不均一染色法
NZ219516A (en) 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
IL99097A0 (en) * 1990-09-05 1992-07-15 Akzo Nv Haemophilus paragallinarum vaccine
US6153406A (en) 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
GB9409962D0 (en) 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds
JPH1084969A (ja) * 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
GB0110431D0 (en) * 2001-04-27 2001-06-20 Glaxosmithkline Biolog Sa Novel compounds
JP2004057078A (ja) 2002-07-29 2004-02-26 Nippon Inst For Biological Science ヘモフィルス・パラガリナルム由来新規ポリペプチドとその遺伝子及び製法
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
EP1961427A3 (en) 2002-08-02 2009-11-04 GlaxoSmithKline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
JP3524546B2 (ja) * 2003-06-18 2004-05-10 富士通株式会社 一覧表画面表示装置
JP4001117B2 (ja) * 2004-02-09 2007-10-31 株式会社微生物化学研究所 ヘモフィルス・パラガリナラムａ型菌由来の感染防御抗原である組み換え蛋白
JP2008029589A (ja) 2006-07-28 2008-02-14 Fujishoji Co Ltd 弾球遊技機
JP2008156317A (ja) 2006-12-26 2008-07-10 Biseibutsu Kagaku Kenkyusho:Kk アビバクテリウム・パラガリナラムｃ型菌由来の発症防御抗原である新規組換え蛋白

Also Published As

Publication number Publication date
CN102333539B (zh) 2014-06-25
US8647634B2 (en) 2014-02-11
EP2853270A1 (en) 2015-04-01
EP2382985B1 (en) 2015-05-06
EP2382985A4 (en) 2013-05-29
US20120003257A1 (en) 2012-01-05
JPWO2010074126A1 (ja) 2012-06-21
ES2616533T3 (es) 2017-06-13
KR101652060B1 (ko) 2016-08-29
CN102333539A (zh) 2012-01-25
EP2382985A1 (en) 2011-11-02
EP2853270B1 (en) 2017-02-08
KR20110114600A (ko) 2011-10-19
ES2537426T3 (es) 2015-06-08
WO2010074126A1 (ja) 2010-07-01
MX2011006903A (es) 2011-09-15
JP5568017B2 (ja) 2014-08-06
US20130183330A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
DK2998315T4 (da) Newcastle sygdomsvirus-bårne fuglevacciner
BR112012012335A2 (pt) polisiloxanos hidrofílicos / lipofílicos modificados como emulsificantes
BR112012004807A2 (pt) vacina para pcsk9
BRPI1014494A2 (pt) vacina pneumocócica e usos da mesma
BRPI0915696A2 (pt) vacina de rotavírus estável, secada, composições e processo para preparação da mesma
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
BRPI0813644A2 (pt) Composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
BRPI1012635A2 (pt) "métodos e composições para imunização contra o vírus"
BRPI1006258A2 (pt) fibra elástica, processo para a preparação de uma fibra elástica, tecido que compreende uma fibra elástica e estrutura de laminado
BRPI0924427A2 (pt) composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
BR112012004176A2 (pt) implemento para cuidado oral
BR112012004178A2 (pt) implemento para cuidado oral, e, aparelho para um implemento oral
BRPI0918365A2 (pt) tramas condutoras e processo para preparação das mesmas
BRPI1014606A2 (pt) Maltotriosil transferase, processo para produção e uso da mesma
BRPI1013561A2 (pt) Processo para a preparação de alogliptina
BRPI1012890A2 (pt) composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit
BR112012003837A2 (pt) vacina aviária de paramyxovirus recombinante e métodos para preparação e uso da mesma
BR112013007486A2 (pt) vacinas de herpesvírus vetorizadas com vírus da doença de newcastle
BRPI1008484A2 (pt) codificador, decodificador e método para os mesmos
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0815602A2 (pt) Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas
BRPI0922173A2 (pt) preparação farmacêutica, e, método para preparar uma preparação farmacêutica
BRPI0808037A2 (pt) Preparação liofilizada contendo vacina contra gripe e método para preparação da mesma.
BRPI0924068A2 (pt) vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma
BRPI1010707A2 (pt) composição farmacêutica, processo para o preparo da mesma, processo para o preparo de uma formulação injetável e formulação injetável

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP)

B25A Requested transfer of rights approved

Owner name: KM BIOLOGICS CO., LTD. (JP)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2650 DE 19-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.